Divya Dhankhar Begins a New Chapter at Gilead Sciences

Gilead Sciences has appointed Divya Dhankhar as Director, Global Digital Innovation & AI, reinforcing its focus on accelerating digital transformation and the adoption of artificial intelligence across the organization.

Announcing the news on LinkedIn, Divya shared her excitement about joining Gilead Sciences and beginning a new chapter in her career, where she will contribute to the company's global digital innovation initiatives.

Driving AI-Powered Innovation in Life Sciences

In her new role, Divya will support Gilead's efforts to harness AI and emerging digital technologies to enhance business processes, improve operational efficiency, and enable innovation across the global organization.

As life sciences companies increasingly invest in AI to accelerate research, streamline operations, and improve decision-making, digital leadership is becoming a critical component of enterprise transformation.

Supporting Gilead's Digital Transformation Journey

Artificial intelligence is rapidly reshaping the pharmaceutical and biotechnology sectors, enabling organizations to uncover insights faster, automate workflows, and improve collaboration across research, development, and commercial functions.

With her appointment, Divya joins Gilead at a time when the company continues to strengthen its digital capabilities to support long-term innovation and business growth.

Expanding AI Leadership in Healthcare

The addition of experienced digital leaders reflects the broader industry shift toward embedding AI into every stage of the healthcare and life sciences value chain. Organizations are increasingly looking to combine technology, data, and scientific expertise to accelerate innovation and deliver greater impact for patients worldwide.

---

About Gilead Sciences

Gilead Sciences is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for life-threatening diseases. The company continues to invest in digital technologies, data, and artificial intelligence to accelerate scientific innovation and improve healthcare outcomes around the world.